New therapies with potential neuro-ophthalmologic toxicity

L. J. Mejico, J. Bergloeff, Neil R Miller

Research output: Contribution to journalArticle

Abstract

Given the ever-increasing number of drugs available for the treatment of a variety of ocular and systemic disorders, it is not surprising that neuro-ophthalmologic complications are being recognized with increasing frequency. In this chapter, we describe both previously unreported (or rarely described) neuro-ophthalmologic complications produced by well known medications and neuro-ophthalmologic complications produced by new medications. The medications discussed include antidepressants, antiepileptic medications, topical antiglaucoma medications, and chemotherapeutic/immunosuppressive agents. Most of the side effects produced by these medications affect visual sensory function; however, some produce disturbances of ocular motility and alignment. Some of these effects are related directly to drug toxicity, whereas others are related to secondary effects of the drug. The heterogeneity of the pathogenesis of side effects from these drugs explains why some of the side effects are reversible, whereas others are not. (C) 2000 Lippincott Williams and Wilkins, Inc.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalCurrent Opinion in Ophthalmology
Volume11
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Immunosuppressive Agents
Pharmaceutical Preparations
Anticonvulsants
Antidepressive Agents
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

New therapies with potential neuro-ophthalmologic toxicity. / Mejico, L. J.; Bergloeff, J.; Miller, Neil R.

In: Current Opinion in Ophthalmology, Vol. 11, No. 6, 2000, p. 389-394.

Research output: Contribution to journalArticle

Mejico, L. J. ; Bergloeff, J. ; Miller, Neil R. / New therapies with potential neuro-ophthalmologic toxicity. In: Current Opinion in Ophthalmology. 2000 ; Vol. 11, No. 6. pp. 389-394.
@article{0dc75c67c3eb48c8a1338469d25d6e02,
title = "New therapies with potential neuro-ophthalmologic toxicity",
abstract = "Given the ever-increasing number of drugs available for the treatment of a variety of ocular and systemic disorders, it is not surprising that neuro-ophthalmologic complications are being recognized with increasing frequency. In this chapter, we describe both previously unreported (or rarely described) neuro-ophthalmologic complications produced by well known medications and neuro-ophthalmologic complications produced by new medications. The medications discussed include antidepressants, antiepileptic medications, topical antiglaucoma medications, and chemotherapeutic/immunosuppressive agents. Most of the side effects produced by these medications affect visual sensory function; however, some produce disturbances of ocular motility and alignment. Some of these effects are related directly to drug toxicity, whereas others are related to secondary effects of the drug. The heterogeneity of the pathogenesis of side effects from these drugs explains why some of the side effects are reversible, whereas others are not. (C) 2000 Lippincott Williams and Wilkins, Inc.",
author = "Mejico, {L. J.} and J. Bergloeff and Miller, {Neil R}",
year = "2000",
doi = "10.1097/00055735-200012000-00002",
language = "English (US)",
volume = "11",
pages = "389--394",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - New therapies with potential neuro-ophthalmologic toxicity

AU - Mejico, L. J.

AU - Bergloeff, J.

AU - Miller, Neil R

PY - 2000

Y1 - 2000

N2 - Given the ever-increasing number of drugs available for the treatment of a variety of ocular and systemic disorders, it is not surprising that neuro-ophthalmologic complications are being recognized with increasing frequency. In this chapter, we describe both previously unreported (or rarely described) neuro-ophthalmologic complications produced by well known medications and neuro-ophthalmologic complications produced by new medications. The medications discussed include antidepressants, antiepileptic medications, topical antiglaucoma medications, and chemotherapeutic/immunosuppressive agents. Most of the side effects produced by these medications affect visual sensory function; however, some produce disturbances of ocular motility and alignment. Some of these effects are related directly to drug toxicity, whereas others are related to secondary effects of the drug. The heterogeneity of the pathogenesis of side effects from these drugs explains why some of the side effects are reversible, whereas others are not. (C) 2000 Lippincott Williams and Wilkins, Inc.

AB - Given the ever-increasing number of drugs available for the treatment of a variety of ocular and systemic disorders, it is not surprising that neuro-ophthalmologic complications are being recognized with increasing frequency. In this chapter, we describe both previously unreported (or rarely described) neuro-ophthalmologic complications produced by well known medications and neuro-ophthalmologic complications produced by new medications. The medications discussed include antidepressants, antiepileptic medications, topical antiglaucoma medications, and chemotherapeutic/immunosuppressive agents. Most of the side effects produced by these medications affect visual sensory function; however, some produce disturbances of ocular motility and alignment. Some of these effects are related directly to drug toxicity, whereas others are related to secondary effects of the drug. The heterogeneity of the pathogenesis of side effects from these drugs explains why some of the side effects are reversible, whereas others are not. (C) 2000 Lippincott Williams and Wilkins, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033663433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033663433&partnerID=8YFLogxK

U2 - 10.1097/00055735-200012000-00002

DO - 10.1097/00055735-200012000-00002

M3 - Article

C2 - 11141631

AN - SCOPUS:0033663433

VL - 11

SP - 389

EP - 394

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 6

ER -